Documents
Application Sponsors
NDA 212156 | PAR STERILE PRODUCTS | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | INJECTABLE;INTRAVENOUS | 50MG | 0 | MICAFUNGIN | MICAFUNGIN SODIUM |
002 | INJECTABLE;INTRAVENOUS | 100MG | 0 | MICAFUNGIN | MICAFUNGIN SODIUM |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2021-06-16 | STANDARD |
Submissions Property Types
CDER Filings
PAR STERILE PRODUCTS
cder:Array
(
[0] => Array
(
[ApplNo] => 212156
[companyName] => PAR STERILE PRODUCTS
[docInserts] => ["",""]
[products] => [{"drugName":"MICAFUNGIN","activeIngredients":"MICAFUNGIN SODIUM","strength":"50MG","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"MICAFUNGIN","activeIngredients":"MICAFUNGIN SODIUM","strength":"100MG","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/16\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/212156Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-06-16
)
)